Abstract
AbstractAsthma is a chronic inflammatory airway disease characterized by airway hyperresponsiveness (AHR), inflammation, and goblet cell hyperplasia. Multiple cytokines, including IFNγ, IL-4, and IL-13 are associated with asthma; however, the mechanisms underlying the effects of these cytokines remain unclear. Here, we report a significant increase in the expression of IL-31RA, but not its cognate ligand IL-31, in mouse models of allergic asthma. In support of this, IFNγ, IL-4, and IL-13 upregulated IL-31RA but not IL-31 in both human and mice primary airway smooth muscle cells (ASMC) isolated from the airways of murine and human lungs. Importantly, the loss of IL-31RA attenuated AHR but had no effect on inflammation and goblet cell hyperplasia in mice challenged with allergens or treated with IL-13 or IFNγ. We show that IL-31RA functions as a positive regulator of muscarinic acetylcholine receptor 3 expression, augmenting calcium levels and myosin light chain phosphorylation in human and murine ASMC. These findings identify a role for IL-31RA in AHR that is distinct from airway inflammation and goblet cell hyperplasia in asthma.
Funder
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference68 articles.
1. Belova, A., Fann, N., Haskell, J., Hubbell, B. & Narayan, T. Estimating lifetime cost of illness. An application to asthma. Ann. Am. Thorac. Soc. 17, 1558–1569 (2020).
2. Czira, A. et al. A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma. Respir. Med. 191, 106670 (2022).
3. Reddel, H. K. et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am. J. Respir. Crit Care Med. 180, 59–99 (2009).
4. Papi, A., Brightling, C., Pedersen, S. E. & Reddel, H. K. Asthma. Lancet 391, 783–800 (2018).
5. Scichilone, N., Battaglia, S., La Sala, A. & Bellia, V. Clinical implications of airway hyperresponsiveness in COPD. Int. J. Chron. Obstruct. Pulmon Dis. 1, 49–60 (2006).